JP2006089487A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006089487A5 JP2006089487A5 JP2005290190A JP2005290190A JP2006089487A5 JP 2006089487 A5 JP2006089487 A5 JP 2006089487A5 JP 2005290190 A JP2005290190 A JP 2005290190A JP 2005290190 A JP2005290190 A JP 2005290190A JP 2006089487 A5 JP2006089487 A5 JP 2006089487A5
- Authority
- JP
- Japan
- Prior art keywords
- citrulline
- active ingredient
- antioxidant
- active
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005290190A JP4691658B2 (en) | 2005-10-03 | 2005-10-03 | Antioxidant food additive |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005290190A JP4691658B2 (en) | 2005-10-03 | 2005-10-03 | Antioxidant food additive |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001027772A Division JP3843298B2 (en) | 2001-02-05 | 2001-02-05 | Active oxygen scavenger containing citrulline |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2006089487A JP2006089487A (en) | 2006-04-06 |
JP2006089487A5 true JP2006089487A5 (en) | 2006-07-20 |
JP4691658B2 JP4691658B2 (en) | 2011-06-01 |
Family
ID=36230788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005290190A Expired - Fee Related JP4691658B2 (en) | 2005-10-03 | 2005-10-03 | Antioxidant food additive |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4691658B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2008105384A1 (en) * | 2007-02-26 | 2010-06-03 | 協和発酵バイオ株式会社 | Citrulline-containing tablets |
JP5288788B2 (en) * | 2007-12-28 | 2013-09-11 | 三菱鉛筆株式会社 | Water-based ink composition |
JP2014045683A (en) * | 2012-08-30 | 2014-03-17 | Fuji Oil Co Ltd | Edible fat and oil, food product containing the same, and production method of the same |
JP2014118405A (en) * | 2012-12-19 | 2014-06-30 | Kose Corp | Dna damage inhibitor |
JP2014129267A (en) * | 2012-12-28 | 2014-07-10 | Kose Corp | DNA damage inhibitor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1267319A (en) * | 1984-09-12 | 1990-04-03 | Godefridus Antonius Maria Van Den Ouweland | Process for improving or modifying the taste and aroma of citrus fruit compositions |
DE4341000A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Use of L-arginine, L-ornithine or L-citrulline and topical preparations with these substances |
JPH09241637A (en) * | 1996-03-14 | 1997-09-16 | Chugai Pharmaceut Co Ltd | Composition for removing active oxygen free radical and removal thereof |
US6028107A (en) * | 1997-02-27 | 2000-02-22 | Waugh; William Howard | Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection |
-
2005
- 2005-10-03 JP JP2005290190A patent/JP4691658B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007299727A8 (en) | Self preserved aqueous pharmaceutical compositions | |
AP2405A (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms. | |
WO2006091529A3 (en) | A solid pharmaceutical dosage formulation | |
ZA200809864B (en) | Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2009137391A3 (en) | Benzene sulfonamide thiazole and oxazole compounds | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
WO2008006528A3 (en) | Pharmaceutical compositions comprising levetiracetam | |
ZA200902632B (en) | Haloalkylsufonanilide derivative or salt thereof, herbicide comprising the derivative as active ingredient, and use of the herbicide | |
EP2607348A3 (en) | Plasminogen Activator Inhibitor-1 Inhibitor | |
WO2008148074A3 (en) | Inhibitors of mtor and methods of treatment using same | |
EP2045253A4 (en) | alpha-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT | |
CL2007003265A1 (en) | COMPOUNDS DERIVED FROM 1H-PIRAN [2,3-D] PIRIMIDIN-2,4,7-TRIONA; AND PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT OF METABOLIC SYNDROME, DYSLIPIDEMIA AND CARDIOVASCULAR DISEASES BETWEEN OTHERS. | |
EP2078731A4 (en) | Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient | |
DK1932522T3 (en) | Liver disease therapeutic agent containing 2-amino-1,3-propanediol derivative as active ingredient | |
NO20080220L (en) | Formulations with high drug loading and dosage forms | |
WO2007009721A3 (en) | Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments | |
WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
WO2010021607A3 (en) | Pharmaceutical formulation | |
WO2007009701A3 (en) | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome | |
WO2006056696A3 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
IL185197A0 (en) | Ophthalmological pharmaceutical compositions | |
IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
JP2006089487A5 (en) | ||
WO2007009686A3 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments |